Friday, October 20, 2023 12:30:59 PM
A composition for treating Amyotrophic Lateral Sclerosis (ALS), comprising induced placental adherent stromal cells (ASC), wherein said induced placental ASC are generated by: (i) expanding placental ASC in an expansion medium lacking
heparin and cAMP, thereby generating expanded placental ASC; and (ii) inducing said expanded placental ASC by incubating said expanded placental ASC in a bioreactor, and wherein said induced placental ASC are indicated for intrathecal administration.
https://patentscope.wipo.int/search/en/detail.jsf?docId=IL406584960&_cid=P12-LNYSXQ-76811-1
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM